Postdoctoral positions in Bardelli Lab
Pubblicato il 14-09-2026 - Linkedin in Roma
IFOM is an internationally recognized non-profit cancer research institute supported by the Italian Association for Cancer Research (AIRC) based in Milan within a highly dynamic urban environment.
IFOM’s continuous success is ensured by the recruitment of highly-competitive undergraduate, graduate and post-graduate researchers worldwide, with over 24 countries currently represented in IFOM.
IFOM labs are hosted within a research campus shared with the European Institute of Oncology and the Italian Institute of Technology.
IFOM is committed to creating a safe and inclusive work environment, based on mutual respect and on the enhancement of diversity, offering equal job opportunities to all qualified candidates.
Sia tra i primi a candidarsi: legga la panoramica completa del ruolo qui sotto, quindi invii la sua candidatura per essere preso/a in considerazione.
We seek for our Institute:
Postdoctoral positions in Bardelli Lab
About the position
The internationally recognized Bardelli Laboratory at IFOM ETS, the AIRC Institute of Molecular Oncology in Milan,
invites applications for a postdoctoral researcher to work on a project focused on understanding the relationship between RNA decay and immunogenicity in colorectal cancer.
Department overview
The position is in Bardelli Lab, under the supervision of Dr. Pietro Paolo Vitiello
Profile Description
We are seeking an independent scientist with a PhD degree and excellent skills in molecular oncology and immunology. Methods will include cell culture, drug screenings, genetic perturbations, multi-omics, and animal experiments.
Your efforts will aim to identify and validate new immunotherapy approaches for immune refractory colorectal tumors.
Language skills
Proficiency in English for speaking and writing - English is the working language at the Institute.
Required skills
Great communication skills and strong motivation to work in a collaborative and constructive lab environment; Good knowledge of cancer biology and